Discordant Reporting of a Previously Undescribed Pathogenic Germline BRCA2 Variant in Blood and Tumor Tissue in a Patient With Pancreatic Adenocarcinoma

JCO Precis Oncol. 2021 Nov:5:974-980. doi: 10.1200/PO.21.00024.

Maximilian Kordes^{1

2}, David Tamborero^{3

4}, Kristina Lagerstedt-Robinson^{5

6}, Jeffrey Yachnin^{3

7}, Richard Rosenquist^{5

6}, J-Matthias Löhr^{1

2}, Maria Gustafsson Liljefors^{1

2}

¹ Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
² Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
³ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
⁴ Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
⁷ Phase-I Unit, Center for Clinical Cancer Studies, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Publication types